Hyaluronan/RHAMM Interactions in Mesenchymal Tumor Pathogenesis

作者: Katerina Kouvidi , Dragana Nikitovic , Aikaterini Berdiaki , George N. Tzanakakis

DOI: 10.1016/B978-0-12-800092-2.00012-5

关键词:

摘要: Fibrosarcoma belongs to the sarcoma cancer group, which are spindle cell malignancies of mesenchymal origin, and owe their name predominant line that is present within tumor. The extracellular matrix (ECM) a complicated structure surrounds supports cells tissues. Its main components proteoglycans, collagens, glycoproteins, hyaluronan (HA), several matrix-degrading enzymes. During progression, significant changes can be observed in structural mechanical properties ECM components. provides physical scaffold tumor attach migrate. Thus, it required for key cellular events such as motility, adhesion, proliferation, invasion, metastasis. Importantly, fibrosarcomas were shown have high content turnover including HA, fibronectin, laminin. In this review, we will focus on HA component fibrosarcoma critically discuss its role involved mechanisms during pathogenesis.

参考文章(175)
Haim Werner, Derek LeRoith, The Role of the Insulin-like Growth Factor System in Human Cancer Advances in Cancer Research. ,vol. 68, pp. 183- 223 ,(1996) , 10.1016/S0065-230X(08)60354-1
Cigdem Yenisey, Renato V. Iozzo, Derrick S. Grant, Bela Sharma, Micaela Mathiak, A Role for Perlecan in the Suppression of Growth and Invasion in Fibrosarcoma Cells Cancer Research. ,vol. 57, pp. 2130- 2136 ,(1997)
Achilleas D. Theocharis, Spyridon S. Skandalis, George N. Tzanakakis, Nikos K. Karamanos, Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS Journal. ,vol. 277, pp. 3904- 3923 ,(2010) , 10.1111/J.1742-4658.2010.07800.X
Hiroshi Koyama, Terumasa Hibi, Zenzo Isogai, Masahiko Yoneda, Minoru Fujimori, Jun Amano, Masatomo Kawakubo, Reiji Kannagi, Koji Kimata, Shun'ichiro Taniguchi, Naoki Itano, Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. American Journal of Pathology. ,vol. 170, pp. 1086- 1099 ,(2007) , 10.2353/AJPATH.2007.060793
Andrew A Butler, Vicky A Blakesley, Maria Tsokos, Vasiliki Pouliki, Teresa L Wood, Derek LeRoith, None, Stimulation of Tumor Growth by Recombinant Human Insulin-like Growth Factor-I (IGF-I) Is Dependent on the Dose and the Level of IGF-I Receptor Expression Cancer Research. ,vol. 58, pp. 3021- 3027 ,(1998)
Endre A. Balazs, Janet L. Denlinger, Clinical uses of hyaluronan. Ciba Foundation Symposium 143 - The Biology of Hyaluronan. ,vol. 143, pp. 265- 285 ,(2007) , 10.1002/9780470513774.CH16
Frances E Lennon, Patrick A Singleton, Hyaluronan regulation of vascular integrity American journal of cardiovascular disease. ,vol. 1, pp. 200- 213 ,(2011)
Hiroshi Koyama, Nobutaka Kobayashi, Michihiko Harada, Michiko Takeoka, Yoshiko Kawai, Kenji Sano, Minoru Fujimori, Jun Amano, Toshio Ohhashi, Reiji Kannagi, Koji Kimata, Shun'ichiro Taniguchi, Naoki Itano, Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. American Journal of Pathology. ,vol. 172, pp. 179- 193 ,(2008) , 10.2353/AJPATH.2008.070360
Joan Massagué, How cells read TGF-beta signals. Nature Reviews Molecular Cell Biology. ,vol. 1, pp. 169- 178 ,(2000) , 10.1038/35043051
Carl-Henrik Heldin, Kohei Miyazono, Peter ten Dijke, TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature. ,vol. 390, pp. 465- 471 ,(1997) , 10.1038/37284